ArticleCancers2026

Melanoma Risk in 12,205 Kidney Transplant Recipients Receiving Calcineurin Inhibitor-Based Immunosuppression: A Nationwide Analysis of Polish National Health Fund Data (2010-2022).

Aleksandra Kulbat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.